The crises at the heart of the government shutdown fight in Washington were coming to a head Saturday as the federal food assistance ...

It is evolutionarily certain that we will have more outbreaks, more pandemics, and frankly, they could be significantly worse ...

Two federal judges ruled nearly simultaneously on Friday that President Trump’s administration must to continue to fund SNAP ...

NIH-led research on structural racism was published Friday, even as the Trump administration has cancelled and discredited ...

A feud between the FDA's Vinay Prasad and his staff is threatening the future of the center that regulates vaccines, ...

Vinay Prasad’s tumultuous tenure at the Food and Drug Administration has entered a new, even rockier era: a slow-boiling feud ...

Dozens of scientists are considering leaving the Center for Biologics Evaluation and Research, where Prasad serves as ...

A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.

Large private insurers have continued to call out purportedly overzealous coding and billing as a source of ballooning health ...

Medicare administrative contracts have proposed eliminating coverage for peripheral nerve block procedures for chronic pain ...

Health care has become a central issue in this year’s elections, a sign of parties' midterm strategies to come.

A new drug-sales king has been crowned. Eli Lilly’s diabetes and weight-loss drug tirzepatide, marketed under the Mounjaro ...